Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Explosions don't stop hair proteins from being used to identify people.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Korean medicine may help with hair growth in alopecia, but more research is needed to confirm this.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

A new method using gentian violet and a protective spray can improve symmetry and reduce surgery time in hair restoration, but it's only effective for total hair loss, not diffuse hair loss or follow-up treatments.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

A new gel helps grow mature eggs in a lab that can be fertilized and develop further.

Acupuncture therapy significantly reduced hair loss in women aged 31-50 with female pattern hair loss.

Patients often experience long-lasting changes to their hair after stem cell transplants.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Mesenchymal stem cells are effective and safe for treating various diseases in children.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.